Michael Golabek

1.9k citations
8 papers · 1.1k indexed · 1 hit paper · h-index 8
Topics
HIV Research and Treatment (8 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)vaccines and immunoinformatics approaches (3 papers)

In The Last Decade

Michael Golabek

8 papers receiving 1.1k citations

Hit Papers

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG50...20132026201720212013200400600

Peers

Michael Golabek
Comparison fields: 5 of 46
  • Virology 966
  • Molecular Biology 518
  • Radiology, Nuclear Medicine and Imaging 439
  • Immunology 410
  • Infectious Diseases 287
Replace Claudia Blattner with:
Claudia Blattner Netherlands
Rajesh P. Ringe India
Jacob Korzun United States
Alba Torrents de la Peña United States
Matthias Pauthner United States
Raiees Andrabi United States
Ronald Derking Netherlands
Krisha McKee United States
Javier Guenaga United States
Anila Yasmeen United States
Michael Golabek relative to Claudia Blattner Netherlands Claudia Blattner's profile →
Citations per field
00.5×1.5×
Claudia Blattner · 1×
Citations per year

Countries citing papers authored by Michael Golabek

Since Specialization
Citations

This map shows the geographic impact of Michael Golabek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Golabek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Golabek more than expected).

Fields of papers citing papers by Michael Golabek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Golabek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Golabek. The network helps show where Michael Golabek may publish in the future.

Co-authorship network of co-authors of Michael Golabek

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Golabek. A scholar is included among the top collaborators of Michael Golabek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Golabek. Michael Golabek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 24
2 65
3 25
4 99
5 177
6 87
7 39
8
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodiesbreakdown →
629

About Michael Golabek

Michael Golabek is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 8 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and vaccines and immunoinformatics approaches (3 papers). The work is most often cited by research in Virology (966 citations), Immunology (410 citations) and Radiology, Nuclear Medicine and Imaging (439 citations). Michael Golabek has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include John P. Moore, Albert Cupo, Per Johan Klasse, Andrew B. Ward, Ian A. Wilson, Rogier W. Sanders, Anila Yasmeen, Thomas J. Ketas, Jean‐Philippe Julien and Helen J. Kim. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Virology and PLoS Pathogens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026